|
|
???tair.name??? >
???browser.page.title.author???
|
"ho cl"???jsp.browse.items-by-author.description???
Showing items 1-25 of 48 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-09-01 |
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study
|
Tsai, HJ;Chen, MH;Wang, HP;Hsiao, CF;Chen, YY;Chen, JS;Yang, MD;Tzen, CY;Shan, YS;Bai, LY;Chan, DC;Chu, PY;Ho, CL;Yang, Y;Lin, J;Lin, HY;Chang, CS;Wang, CC;Hwang, TL;Chen, LT |
| 國家衛生研究院 |
2025-07-25 |
Functional diversity of two novel embryonic microglial subpopulations and their developmental trajectories in developing mouse brains
|
Cheng, SM;Ho, CL;Chen, SL;Huang, YT;Mao, PC;Lin, TC;Chen, JS;Sun, HS;Hwang, DY;Chu, CH |
| 國家衛生研究院 |
2025-02 |
Durvalumab, tremelimumab, and platinum chemotherapy in EGFR mutation–positive NSCLC: An open-label Phase 2 trial (ILLUMINATE)
|
Lee, CK;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, AJ;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Ford, K;Cummins, MM;Stockler, MR;Solomon, BJ;John, T;Chih-Hsin Yang, J |
| 國家衛生研究院 |
2024-09-30 |
Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521
|
Liao, BC;Chiang, NJ;Chang, GC;Su, WC;Luo, YH;Chong, IW;Yang, TY;Lai, CL;Hsia, TC;Ho, CL;Lee, KY;Hsiao, CF;Ku, FC;Fang, WT;Chih-Hsin Yang, J |
| 國家衛生研究院 |
2024-08-21 |
Immune killer cells treatment for previously treated stage IV NSCLC patients
|
Tseng, YH;Ho, CL;Chian, CF;Chiang, CL;Chao, HS;Tsai, CL;Perng, WC;Hsiao, CF;Chuang, MH;Ko, KH;Cheng, YC;Chen, SJ;Wang, CJ;Chen, YM |
| 國家衛生研究院 |
2024-07-11 |
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study
|
Tsai, HJ;Shan, YS;Yang, CY;Hsiao, CF;Tsai, CH;Wang, CC;Lin, MT;Ting, CF;Chan, DC;Chen, TH;Yen, CC;Chen, YY;Lin, HY;Yeh, TS;Ho, CL;Shieh, TY;Bai, LY;Hsu, JT;Chen, IS;Chen, LT;Yeh, CN;Liu, TW;Chuang, CH;Wang, TE |
| 國家衛生研究院 |
2024-03-12 |
Long-term analysis of humoral responses and spike-specific T cell memory to Omicron variants after different COVID-19 vaccine regimens
|
Ho, CL;Yen, LC;Huang, HW;Lu, CC;Hung, YJ;Liao, CL;Hung, CM;Chiu, KC |
| 國家衛生研究院 |
2023-11 |
Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome
|
Su, YY;Lin, YJ;Hsiao, CF;Ou, DL;Chen, SC;Wang, HW;Wang, JH;Wu, YM;Lee, WC;Chou, SC;Ho, CL;Chiu, CF;Chen, LT;Shen, YS;Cheng, AL;Hsu, C |
| 國家衛生研究院 |
2023-11 |
The registry of genetic alterations of Taiwan NSCLC by comprehensive next-generation sequencing: A real-world cohort study - TCOG T1521 study
|
Liao, BC;Chiang, NJ;Chang, GC;Su, WC;Chong, IW;Yang, TY;Luo, YH;Lai, CL;Hsia, TC;Ho, CL;Lee, KY;Hsiao, CF;Yang, JCH |
| 國家衛生研究院 |
2023-11 |
ILLUMINATE: Efficacy and safety of durvalumab-tremelimumab and chemotherapy in EGFR mutant NSCLC following progression on EGFR inhibitors
|
Lee, C;Liao, BC;Subramaniam, S;Chiu, CH;Mersiades, A;Ho, CC;Brown, C;Lai, CL;Hughes, BGM;Yang, TY;O'Byrne, K;Luo, YH;Yip, S;Ho, CL;Bray, V;Su, WC;Moore, M;Feng, WL;Bai, YY;Stockler, M;Solomon, B;John, T;Yang, JCH |
| 國家衛生研究院 |
2023-06-14 |
Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement
|
Yen, LC;Chen, HW;Ho, CL;Lin, CC;Lin, YL;Yang, QW;Chiu, KC;Lien, SP;Lin, RJ;Liao, CL |
| 國家衛生研究院 |
2023-04-11 |
Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized
|
Chiu, YF;Liu, TW;Shan, YS;Chen, JS;Li, CP;Ho, CL;Hsieh, RK;Hwang, TL;Chen, LT;Ch'ang, HJ; Taiwan Cooperative Oncology Group pancreatic cancer study group, |
| 國家衛生研究院 |
2023-04-04 |
Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer
|
Lee, CT;Chu, CA;Wang, YM;Wang, YW;Chen, YL;Ho, CL;Yeh, YM;Lin, PC;Lin, BW;Chen, PC;Chen, SH;Chan, RH;Chang, C;Chow, NH |
| 國家衛生研究院 |
2022-11-03 |
Return to work and mortality in breast cancer survivors: A 11-year longitudinal study
|
Yang, ZY;Chen, WL;Wu, WT;Lai, CH;Ho, CL;Wang, CC |
| 國家衛生研究院 |
2021-06-18 |
Life expectancy estimations and determinants of return to work among cancer survivors over a 7-year period
|
Chen, WL;Chen, YY;Wu, WT;Ho, CL;Wang, CC |
| 國家衛生研究院 |
2021-05-14 |
Risk factors for return to work in colorectal cancer survivors
|
Yuan, CM;Wang, CC;Wu, WT;Ho, CL;Chen, WL |
| 國家衛生研究院 |
2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ |
| 國家衛生研究院 |
2021-03-04 |
Nasal microbiome change during and after exacerbation in asthmatic children
|
Liu, T;Lin, CH;Chen, YL;Jeng, SL;Tsai, HJ;Ho, CL;Kuo, WS;Hsieh, MH;Chen, PC;Wu, LS;Wang, JY |
| 國家衛生研究院 |
2019-12 |
Trajectories of returning to work and its impact on survival in survivors with oral cancer: A 5-year follow-up study
|
Chen, YY;Wang, CC;Wu, WT;Lai, CH;Ho, CL;Hsu, YY;Chen, WL |
| 國家衛生研究院 |
2018-10 |
Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study
|
Chang, HJ;Chiu, YF;Chen, JS;Li, CP;Ho, CL;Shyr, YM;Chiou, WC;Yeh, CN;Hsieh, RK;Lin, YL;Tien, YW;Hwang, TL;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2018-09-28 |
CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia
|
Chiang, YJ;Liao, WT;Ho, KC;Wang, SH;Chen, YG;Ho, CL;Huang, SF;Shih, LY;Yang-Yen, HF;Yen, JJ |
| 國家衛生研究院 |
2016-03 |
The clinical efficacy and cardiotoxicity of fixed-dose monthly trastuzumab in HER2-positive breast cancer: A single institutional analysis
|
Wu, YY;Huang, TC;Tsai, TN;Chen, JH;Dai, MS;Chang, PY;Ho, CL;Ye, RH;Chung, TR;Chen, YC;Chao, TY |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 中國醫藥大學 |
2015-05 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
|
(Chiu CH)*;(Yang CT);(Shih JY);(Huang MS);(Su WC);(Lai RS);(Wang CC);(Hsiao SH);(Lin YC);(Ho CL);夏德椿(Te-Chun Hsia);(Wu MF) |
| 國立交通大學 |
2014-12-08T15:41:01Z |
A low-complexity adaptive multi-beam space-time receiver for CCI/ISI cancellation over frequency selective multipath channels
|
Ho, CL; Lee, TS |
Showing items 1-25 of 48 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
